This arrangement is not a classic partnership , as Amarantus is maintaining all intellectual property rights to current and future versions of LymPro at the current time. This is a services agreement that gets the ball rolling on the CLIA process as we make progress on our ongoing LP-002 clinical study and puts Icon in a sub-contractor relationship with respect to LymPro. -

These are the words that jump out to me.

adding "current time" in there could imply thinks may change shortly